» Authors » Ian L McAllister

Ian L McAllister

Explore the profile of Ian L McAllister including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 102
Citations 2579
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Bhandari S, Nguyen V, Hunt A, Gabrielle P, Viola F, Mehta H, et al.
Eye (Lond) . 2022 May; 37(6):1145-1154. PMID: 35508721
Objectives: To identify whether the outcomes of neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO) and retinal vein occlusion (RVO) in routine clinical practice have changed over time. Methods:...
12.
Heath Jeffery R, Thompson J, Lo J, Lamey T, McLaren T, De Roach J, et al.
Retina . 2022 Mar; 42(8):1545-1559. PMID: 35344533
Purpose: To investigate concordance in symptom onset, area of dark autofluorescence (DAF), and growth rate (GR) between Stargardt disease siblings at an age-matched time point. Methods: In this retrospective longitudinal...
13.
Hunt A, Nguyen V, Arnold J, McAllister I, Mehta H, Invernizzi A, et al.
Br J Ophthalmol . 2022 Jan; 107(6):842-848. PMID: 35078771
Background/aims: To describe baseline characteristics and 12-month outcomes with vascular endothelial growth factor (VEGF) inhibitors of treatment-naïve hemiretinal vein occlusion (HRVO) compared with branch (BRVO) and central (CRVO) variants in...
14.
Heath Jeffery R, Thompson J, Lo J, Lamey T, McLaren T, McAllister I, et al.
Genes (Basel) . 2021 Dec; 12(12). PMID: 34946930
Reported growth rates (GR) of atrophic lesions in Stargardt disease (STGD1) vary widely. In the present study, we report the longitudinal natural history of patients with confirmed biallelic mutations from...
15.
Heath Jeffery R, Mukhtar S, Lopez D, Preen D, McAllister I, Mackey D, et al.
Asia Pac J Ophthalmol (Phila) . 2021 Sep; 10(5):442-449. PMID: 34534144
Purpose: Report the age-standardized annual incidence of blindness registration due to age-related macular degeneration (AMD) in Australia in patients aged 50 years and older. Frequencies of photodynamic therapy (PDT) and...
16.
Niedzwiecki M, Hunt A, Nguyen V, Mehta H, Creuzot-Garcher C, Gabrielle P, et al.
Acta Ophthalmol . 2021 Sep; 100(4):e920-e927. PMID: 34519167
Purpose: To compare 12-month treatment outcomes of eyes receiving aflibercept or ranibizumab for macular oedema secondary to central retinal vein occlusion (CRVO) in routine clinical practice. Methods: 296 treatment-naïve eyes...
17.
Cornish E, Teo K, Gillies M, Lim L, Nguyen V, Wickremasinghe S, et al.
Br J Ophthalmol . 2021 Aug; 107(1):79-83. PMID: 34340975
Background: The BEVORDEX trial compared outcomes of eyes with diabetic macular oedema (DMO) randomised to receive either intravitreal dexamethasone (DEX-) implant or bevacizumab over 2 years. We assessed long-term efficacy...
18.
Heath Jeffery R, Thompson J, Lamey T, McLaren T, McAllister I, Constable I, et al.
Retina . 2021 Jun; 41(12):2578-2588. PMID: 34125082
Purpose: To establish a mutation-specific age-dependent ultra-widefield fundus autofluorescence (UWF-FAF) trajectory in a large Stargardt disease (STGD1) cohort using total lesion size (TLS) and to develop a clinical method for...
19.
Heath Jeffery R, Mukhtar S, McAllister I, Morgan W, Mackey D, Chen F
Ophthalmic Genet . 2021 May; 42(4):431-439. PMID: 33939573
This study examined the frequency of inherited retinal diseases (IRDs) as the reason for blindness registrations over the last two decades and the demographic and clinical phenotypes of inherited retinal...
20.
McAllister I, Smithies L, Chen F, Mackey D, Sanfilippo P
BMJ Open Ophthalmol . 2021 Mar; 6(1):e000728. PMID: 33768164
Objective: To evaluate the functional benefits (best corrected visual acuity (BCVA), central subfield thickness, injection loads, central venous pressure (CVP)) of a laser-induced chorioretinal anastomosis (L-CRA) in patients with central...